Primary cutaneous T cell lymphomas (CTCLs) are a heterogeneous group of lymphomas
that present in the skin with no evidence of extracutaneous disease at the time of diagnosis …

In order to provide a common standard for the treatment of mycosis fungoides (MF) and
Sézary syndrome (SS), the European Organisation for Research and Treatment of Cancer …

Background Cutaneous T-cell lymphomas are rare non-Hodgkin lymphomas with
substantial morbidity and mortality in advanced disease stages. We compared the efficacy of …

Cutaneous T cell lymphomas (CTCL) are rare but aggressive cancers without effective
treatments. While a subset of patients derive benefit from PD-1 blockade, there is a critically …

Primary cutaneous lymphomas (PCLs) are defined as non-Hodgkin lymphomas that present
in the skin with no evidence of extracutaneous disease at the time of diagnosis. After …

Background Survival in mycosis fungoides (MF) is varied and may be poor. The PROCLIPI
(PRO spective Cutaneous Lymphoma International Prognostic Index) study is a web‐based …

PURPOSE To assess the efficacy of pembrolizumab in patients with advanced relapsed or
refractory mycosis fungoides (MF) or Sézary syndrome (SS). PATIENTS AND METHODS …

Background Advanced-stage cutaneous T-cell lymphomas (CTCLs) are rare, usually
refractory, and fatal diseases. Case series have suggested that allogeneic haematopoietic …

Simple Summary Cutaneous T-cell lymphomas (CTCL) are rare malignant diseases. In this
study we have compared the cutaneous lymphoma registries of different countries, which …

British Association of Dermatologists and UK Cutaneous Lymphoma Group guidelines for the
management of primary cutaneous lymphomas 2018 | British Journal of Dermatology | Oxford …